Document is current

Any future updates will be listed below

Efficacy and Safety of GPR119 Agonist DS-8500a in Japanese Patients with Type 2 Diabetes: a Randomized, Double-Blind, Placebo-Controlled, 12-Week Study

Crossref DOI link: https://doi.org/10.1007/s12325-018-0668-2

Published Online: 2018-02-27

Published Print: 2018-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark